Mirabella Financial Services LLP Catalent, Inc. Transaction History

Mirabella Financial Services LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$45.44 - $74.26 $6.75 Million - $11 Million	-148,589 Reduced 81.09%	34,654 $2.28 Million
Q4 2022 Feb 13, 2023	BUY	$41.39 - $81.0 $7.58 Million - $14.8 Million	183,243 New	183,243 $8.24 Million
Q2 2022 Aug 12, 2022	BUY	$87.2 - $114.05 $3.55 Million - $4.65 Million	40,760 New	40,760 $4.37 Million
Q1 2022 May 17, 2022	SELL	$94.19 - $124.49 $3.67 Million - $4.86 Million	-39,004 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$119.57 - $139.07 $161,299 - $187,605	1,349 Added 3.58%	39,004 $4.99 Million
Q3 2021 Nov 15, 2021	BUY	$109.17 - $142.35 $4.11 Million - $5.36 Million	37,655 New	37,655 $5.01 Million
Q1 2021 May 17, 2021	SELL	$101.51 - $125.27 $275,295 - $339,732	-2,712 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$85.88 - $105.36 $232,906 - $285,736	2,712 New	2,712 $282,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Mirabella Financial Services LLP, based on Form 13F filings with the SEC.

Stay updated on Mirabella Financial Services LLP with notifications on news.